Drug Trial Radar · NCT01456052
A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: May 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
59
Actual
Start
Jan 30, 2012
Primary completion
Sep 3, 2013
Study completion Sep 3, 2013
Sponsor
- Lead sponsor
- Lexicon PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 20, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, placebo-controlled, parallel-group, pilot study to evaluate safety and preliminary effectiveness of two blinded dose levels of telotristat etiprate (LX1606) in participants with acute, mild to moderate ulcerative colitis on 5-aminosalicylic acid/mesalamine therapy.
Conditions
- Ulcerative Colitis
Interventions
Telotristat EtiprateDrug
500 mg telotristat etiprate (LX1606) administered orally.
PlaceboDrug
Matching placebo administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Experiencing a Treatment Emergent Adverse EventTime frame: 8 weeks
Locations
24 sites in 4 countries. Site status is shown where the registry gives one.
Lexicon Investigational Site
Little Rock, Arkansas
Lexicon Investigational Site
Anaheim, California
Lexicon Investigational Site
Santa Monica, California
Lexicon Investigational Site
Great Neck, New York
Lexicon Investigational Site
New York, New York
Lexicon Investigational Site
Tulsa, Oklahoma
Lexicon Investigational Site
Houston, Texas
Lexicon Investigational Site
San Antonio, Texas
Lexicon Investigational Site
Ogden, Utah
Lexicon Investigational Site
Sandy City, Utah
Lexicon Investigational Site
Seattle, Washington
Lexicon Investigational Site
Kaunas, Lithuania
Lexicon Investigational Site
Klaipėda, Lithuania
Lexicon Investigational Site
Šiauliai, Lithuania
Lexicon Investigational Site
Vilnius, Lithuania
Lexicon Investigational Site
Vilnius, Lithuania
Lexicon Investigational Site
Krakow, Poland
Lexicon Investigational Site
Lodz, Poland
Lexicon Investigational Site
Sopot, Poland
Lexicon Investigational Site
Warsaw, Poland
Lexicon Investigational Site
Wroclaw, Poland
Lexicon Investigational Site
Wroclaw, Poland
Lexicon Investigational Site
Nitra, Slovakia
Lexicon Investigational Site
Nové Mesto nad Váhom, Slovakia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.